Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1056/NEJMc2414069 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Myelodysplasia after Lentiviral Gene Therapy. Reply.
N Engl J Med
December 2024
Boston Children's Hospital, Boston, MA
Myelodysplasia after Lentiviral Gene Therapy.
N Engl J Med
December 2024
Federal University of Ceara, Fortaleza, Brazil
Myelodysplasia after Lentiviral Gene Therapy.
N Engl J Med
December 2024
St. Jude Children's Research Hospital, Memphis, TN
Myelodysplasia after Lentiviral Gene Therapy.
N Engl J Med
December 2024
San Raffaele Telethon Institute for Gene Therapy, Milan, Italy.
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Oncotarget
January 2017
Department of Internal Medicine, Medical School of Ribeirao Preto, Brazil.
Here, we evaluated whether the overexpression of transcriptionally inactive ΔNp73 cooperates with PML/RARA fusion protein in the induction of an APL-leukemic phenotype, as well as its role in vitro in proliferation, myeloid differentiation, and drug-induced apoptosis. Using lentiviral gene transfer, we showed in vitro that ΔNp73 overexpression resulted in increased proliferation in murine bone marrow (BM) cells from hCG-PML/RARA transgenic mice and their wild-type (WT) counterpart, with no accumulation of cells at G2/M or S phases; instead, ΔNp73-expressing cells had a lower rate of induced apoptosis. Next, we evaluated the effect of ΔNp73 on stem-cell self-renewal and myeloid differentiation.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!